Skip to content

Bio-Mycin (Erythromycin): Uses, Side Effects, and Safety

Published: July 26, 2026Updated: September 3, 2026

Bio-Mycin is a brand name for erythromycin, a macrolide antibiotic used to treat certain bacterial infections. It works by stopping bacteria from growing and does not treat viral illnesses such as colds or flu.

Quick summary

Take Bio-Mycin exactly as prescribed and finish the full course unless your clinician tells you to stop. Ask a doctor or pharmacist for advice if you have liver, heart, or digestive conditions or take other medicines.

Medically reviewed by WellAlly Editorial TeamLast reviewed September 3, 2026Editorial policy

Key facts at a glance

RxNorm
1094904
Generic
Bio-Mycin
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed September 3, 2026. · Read our editorial policy